Global TDS(Transdermal Delivery Systems) Sales Market Report 2024
The global TDS(Transdermal Delivery Systems) market is segmented by company, region (country), by Type, and by Application. Players, stakeholders, and other participants in the global TDS(Transdermal Delivery Systems) market will be able to gain the upper hand as they use the report as a powerful resource. The segmental analysis focuses on sales, revenue and forecast by region (country), by Type and by Application for the period 2016-2027.
Segment by Type
Single-layer Drug-in-Adhesive
Multi-layer Drug-in-Adhesive
Others
Segment by Application
Hospital
Clinic
Other
The TDS(Transdermal Delivery Systems) market is analysed and market size information is provided by regions (countries).
Segment by Application
, the TDS(Transdermal Delivery Systems) market is segmented into North America, Europe, China, Japan, Southeast Asia, India and Other Regions.
By Company
Adhex Pharma
Harro Hofliger
Tesa Labtec
Toyochem
Teva Pharmaceutical
Pfizer
IBSA Group
Teikoku Seiyaku
Endo International
Hisamitsu
Mylan
Sorrento Therapeutics
Table of Content
1 TDS(Transdermal Delivery Systems) Market Overview
1.1 TDS(Transdermal Delivery Systems) Product Scope
1.2 TDS(Transdermal Delivery Systems) Segment by Type
1.2.1 Global TDS(Transdermal Delivery Systems) Sales by Type (2016 & 2021 & 2027)
1.2.2 Single-layer Drug-in-Adhesive
1.2.3 Multi-layer Drug-in-Adhesive
1.2.4 Others
1.3 TDS(Transdermal Delivery Systems) Segment by Application
1.3.1 Global TDS(Transdermal Delivery Systems) Sales Comparison by Application (2016 & 2021 & 2027)
1.3.2 Hospital
1.3.3 Clinic
1.3.4 Other
1.4 TDS(Transdermal Delivery Systems) Market Estimates and Forecasts (2016-2027)
1.4.1 Global TDS(Transdermal Delivery Systems) Market Size in Value Growth Rate (2016-2027)
1.4.2 Global TDS(Transdermal Delivery Systems) Market Size in Volume Growth Rate (2016-2027)
1.4.3 Global TDS(Transdermal Delivery Systems) Price Trends (2016-2027)
2 TDS(Transdermal Delivery Systems) Estimates and Forecasts by Region
2.1 Global TDS(Transdermal Delivery Systems) Market Size by Region: 2016 VS 2021 VS 2027
2.2 Global TDS(Transdermal Delivery Systems) Retrospective Market Scenario by Region (2016-2021)
2.2.1 Global TDS(Transdermal Delivery Systems) Sales Market Share by Region (2016-2021)
2.2.2 Global TDS(Transdermal Delivery Systems) Revenue Market Share by Region (2016-2021)
2.3 Global TDS(Transdermal Delivery Systems) Market Estimates and Forecasts by Region (2022-2027)
2.3.1 Global TDS(Transdermal Delivery Systems) Sales Estimates and Forecasts by Region (2022-2027)
2.3.2 Global TDS(Transdermal Delivery Systems) Revenue Forecast by Region (2022-2027)
2.4 Geographic Market Analysis: Market Facts & Figures
2.4.1 North America TDS(Transdermal Delivery Systems) Estimates and Projections (2016-2027)
2.4.2 Europe TDS(Transdermal Delivery Systems) Estimates and Projections (2016-2027)
2.4.3 China TDS(Transdermal Delivery Systems) Estimates and Projections (2016-2027)
2.4.4 Japan TDS(Transdermal Delivery Systems) Estimates and Projections (2016-2027)
2.4.5 Southeast Asia TDS(Transdermal Delivery Systems) Estimates and Projections (2016-2027)
2.4.6 India TDS(Transdermal Delivery Systems) Estimates and Projections (2016-2027)
3 Global TDS(Transdermal Delivery Systems) Competition Landscape by Players
3.1 Global Top TDS(Transdermal Delivery Systems) Players by Sales (2016-2021)
3.2 Global Top TDS(Transdermal Delivery Systems) Players by Revenue (2016-2021)
3.3 Global TDS(Transdermal Delivery Systems) Market Share by Company Type (Tier 1, Tier 2 and Tier 3) & (based on the Revenue in TDS(Transdermal Delivery Systems) as of 2020)
3.4 Global TDS(Transdermal Delivery Systems) Average Price by Company (2016-2021)
3.5 Manufacturers TDS(Transdermal Delivery Systems) Manufacturing Sites, Area Served, Product Type
3.6 Manufacturers Mergers & Acquisitions, Expansion Plans
4 Global TDS(Transdermal Delivery Systems) Market Size by Type
4.1 Global TDS(Transdermal Delivery Systems) Historic Market Review by Type (2016-2021)
4.1.1 Global TDS(Transdermal Delivery Systems) Sales Market Share by Type (2016-2021)
4.1.2 Global TDS(Transdermal Delivery Systems) Revenue Market Share by Type (2016-2021)
4.1.3 Global TDS(Transdermal Delivery Systems) Price by Type (2016-2021)
4.2 Global TDS(Transdermal Delivery Systems) Market Estimates and Forecasts by Type (2022-2027)
4.2.1 Global TDS(Transdermal Delivery Systems) Sales Forecast by Type (2022-2027)
4.2.2 Global TDS(Transdermal Delivery Systems) Revenue Forecast by Type (2022-2027)
4.2.3 Global TDS(Transdermal Delivery Systems) Price Forecast by Type (2022-2027)
5 Global TDS(Transdermal Delivery Systems) Market Size by Application
5.1 Global TDS(Transdermal Delivery Systems) Historic Market Review by Application (2016-2021)
5.1.1 Global TDS(Transdermal Delivery Systems) Sales Market Share by Application (2016-2021)
5.1.2 Global TDS(Transdermal Delivery Systems) Revenue Market Share by Application (2016-2021)
5.1.3 Global TDS(Transdermal Delivery Systems) Price by Application (2016-2021)
5.2 Global TDS(Transdermal Delivery Systems) Market Estimates and Forecasts by Application (2022-2027)
5.2.1 Global TDS(Transdermal Delivery Systems) Sales Forecast by Application (2022-2027)
5.2.2 Global TDS(Transdermal Delivery Systems) Revenue Forecast by Application (2022-2027)
5.2.3 Global TDS(Transdermal Delivery Systems) Price Forecast by Application (2022-2027)
6 North America TDS(Transdermal Delivery Systems) Market Facts & Figures
6.1 North America TDS(Transdermal Delivery Systems) Sales by Company
6.1.1 North America TDS(Transdermal Delivery Systems) Sales by Company (2016-2021)
6.1.2 North America TDS(Transdermal Delivery Systems) Revenue by Company (2016-2021)
6.2 North America TDS(Transdermal Delivery Systems) Sales Breakdown by Type
6.2.1 North America TDS(Transdermal Delivery Systems) Sales Breakdown by Type (2016-2021)
6.2.2 North America TDS(Transdermal Delivery Systems) Sales Breakdown by Type (2022-2027)
6.3 North America TDS(Transdermal Delivery Systems) Sales Breakdown by Application
6.3.1 North America TDS(Transdermal Delivery Systems) Sales Breakdown by Application (2016-2021)
6.3.2 North America TDS(Transdermal Delivery Systems) Sales Breakdown by Application (2022-2027)
7 Europe TDS(Transdermal Delivery Systems) Market Facts & Figures
7.1 Europe TDS(Transdermal Delivery Systems) Sales by Company
7.1.1 Europe TDS(Transdermal Delivery Systems) Sales by Company (2016-2021)
7.1.2 Europe TDS(Transdermal Delivery Systems) Revenue by Company (2016-2021)
7.2 Europe TDS(Transdermal Delivery Systems) Sales Breakdown by Type
7.2.1 Europe TDS(Transdermal Delivery Systems) Sales Breakdown by Type (2016-2021)
7.2.2 Europe TDS(Transdermal Delivery Systems) Sales Breakdown by Type (2022-2027)
7.3 Europe TDS(Transdermal Delivery Systems) Sales Breakdown by Application
7.3.1 Europe 147 Sales Breakdown by Application (2016-2021)
7.3.2 Europe 147 Sales Breakdown by Application (2022-2027)
8 China TDS(Transdermal Delivery Systems) Market Facts & Figures
8.1 China TDS(Transdermal Delivery Systems) Sales by Company
8.1.1 China TDS(Transdermal Delivery Systems) Sales by Company (2016-2021)
8.1.2 China TDS(Transdermal Delivery Systems) Revenue by Company (2016-2021)
8.2 China TDS(Transdermal Delivery Systems) Sales Breakdown by Type
8.2.1 China TDS(Transdermal Delivery Systems) Sales Breakdown by Type (2016-2021)
8.2.2 China TDS(Transdermal Delivery Systems) Sales Breakdown by Type (2022-2027)
8.3 China TDS(Transdermal Delivery Systems) Sales Breakdown by Application
8.3.1 China 312 Sales Breakdown by Application (2016-2021)
8.3.2 China 312 Sales Breakdown by Application (2022-2027)
9 Japan TDS(Transdermal Delivery Systems) Market Facts & Figures
9.1 Japan TDS(Transdermal Delivery Systems) Sales by Company
9.1.1 Japan TDS(Transdermal Delivery Systems) Sales by Company (2016-2021)
9.1.2 Japan TDS(Transdermal Delivery Systems) Revenue by Company (2016-2021)
9.2 Japan TDS(Transdermal Delivery Systems) Sales Breakdown by Type
9.2.1 Japan TDS(Transdermal Delivery Systems) Sales Breakdown by Type (2016-2021)
9.2.2 Japan TDS(Transdermal Delivery Systems) Sales Breakdown by Type (2022-2027)
9.3 Japan TDS(Transdermal Delivery Systems) Sales Breakdown by Application
9.3.1 Japan Feb. Sales Breakdown by Application (2016-2021)
9.3.2 Japan Feb. Sales Breakdown by Application (2022-2027)
10 Southeast Asia TDS(Transdermal Delivery Systems) Market Facts & Figures
10.1 Southeast Asia TDS(Transdermal Delivery Systems) Sales by Company
10.1.1 Southeast Asia TDS(Transdermal Delivery Systems) Sales by Company (2016-2021)
10.1.2 Southeast Asia TDS(Transdermal Delivery Systems) Revenue by Company (2016-2021)
10.2 Southeast Asia TDS(Transdermal Delivery Systems) Sales Breakdown by Type
10.2.1 Southeast Asia TDS(Transdermal Delivery Systems) Sales Breakdown by Type (2016-2021)
10.2.2 Southeast Asia TDS(Transdermal Delivery Systems) Sales Breakdown by Type (2022-2027)
10.3 Southeast Asia TDS(Transdermal Delivery Systems) Sales Breakdown by Application
10.3.1 Southeast Asia K Units Sales Breakdown by Application (2016-2021)
10.3.2 Southeast Asia K Units Sales Breakdown by Application (2022-2027)
11 India TDS(Transdermal Delivery Systems) Market Facts & Figures
11.1 India TDS(Transdermal Delivery Systems) Sales by Company
11.1.1 India TDS(Transdermal Delivery Systems) Sales by Company (2016-2021)
11.1.2 India TDS(Transdermal Delivery Systems) Revenue by Company (2016-2021)
11.2 India TDS(Transdermal Delivery Systems) Sales Breakdown by Type
11.2.1 India TDS(Transdermal Delivery Systems) Sales Breakdown by Type (2016-2021)
11.2.2 India TDS(Transdermal Delivery Systems) Sales Breakdown by Type (2022-2027)
11.3 India TDS(Transdermal Delivery Systems) Sales Breakdown by Application
11.3.1 India TDS(Transdermal Delivery Systems) Sales Breakdown by Application (2016-2021)
11.3.2 India TDS(Transdermal Delivery Systems) Sales Breakdown by Application (2022-2027)
12 Company Profiles and Key Figures in TDS(Transdermal Delivery Systems) Business
12.1 Adhex Pharma
12.1.1 Adhex Pharma Corporation Information
12.1.2 Adhex Pharma Business Overview
12.1.3 Adhex Pharma TDS(Transdermal Delivery Systems) Sales, Revenue and Gross Margin (2016-2021)
12.1.4 Adhex Pharma TDS(Transdermal Delivery Systems) Products Offered
12.1.5 Adhex Pharma Recent Development
12.2 Harro Hofliger
12.2.1 Harro Hofliger Corporation Information
12.2.2 Harro Hofliger Business Overview
12.2.3 Harro Hofliger TDS(Transdermal Delivery Systems) Sales, Revenue and Gross Margin (2016-2021)
12.2.4 Harro Hofliger TDS(Transdermal Delivery Systems) Products Offered
12.2.5 Harro Hofliger Recent Development
12.3 Tesa Labtec
12.3.1 Tesa Labtec Corporation Information
12.3.2 Tesa Labtec Business Overview
12.3.3 Tesa Labtec TDS(Transdermal Delivery Systems) Sales, Revenue and Gross Margin (2016-2021)
12.3.4 Tesa Labtec TDS(Transdermal Delivery Systems) Products Offered
12.3.5 Tesa Labtec Recent Development
12.4 Toyochem
12.4.1 Toyochem Corporation Information
12.4.2 Toyochem Business Overview
12.4.3 Toyochem TDS(Transdermal Delivery Systems) Sales, Revenue and Gross Margin (2016-2021)
12.4.4 Toyochem TDS(Transdermal Delivery Systems) Products Offered
12.4.5 Toyochem Recent Development
12.5 Teva Pharmaceutical
12.5.1 Teva Pharmaceutical Corporation Information
12.5.2 Teva Pharmaceutical Business Overview
12.5.3 Teva Pharmaceutical TDS(Transdermal Delivery Systems) Sales, Revenue and Gross Margin (2016-2021)
12.5.4 Teva Pharmaceutical TDS(Transdermal Delivery Systems) Products Offered
12.5.5 Teva Pharmaceutical Recent Development
12.6 Pfizer
12.6.1 Pfizer Corporation Information
12.6.2 Pfizer Business Overview
12.6.3 Pfizer TDS(Transdermal Delivery Systems) Sales, Revenue and Gross Margin (2016-2021)
12.6.4 Pfizer TDS(Transdermal Delivery Systems) Products Offered
12.6.5 Pfizer Recent Development
12.7 IBSA Group
12.7.1 IBSA Group Corporation Information
12.7.2 IBSA Group Business Overview
12.7.3 IBSA Group TDS(Transdermal Delivery Systems) Sales, Revenue and Gross Margin (2016-2021)
12.7.4 IBSA Group TDS(Transdermal Delivery Systems) Products Offered
12.7.5 IBSA Group Recent Development
12.8 Teikoku Seiyaku
12.8.1 Teikoku Seiyaku Corporation Information
12.8.2 Teikoku Seiyaku Business Overview
12.8.3 Teikoku Seiyaku TDS(Transdermal Delivery Systems) Sales, Revenue and Gross Margin (2016-2021)
12.8.4 Teikoku Seiyaku TDS(Transdermal Delivery Systems) Products Offered
12.8.5 Teikoku Seiyaku Recent Development
12.9 Endo International
12.9.1 Endo International Corporation Information
12.9.2 Endo International Business Overview
12.9.3 Endo International TDS(Transdermal Delivery Systems) Sales, Revenue and Gross Margin (2016-2021)
12.9.4 Endo International TDS(Transdermal Delivery Systems) Products Offered
12.9.5 Endo International Recent Development
12.10 Hisamitsu
12.10.1 Hisamitsu Corporation Information
12.10.2 Hisamitsu Business Overview
12.10.3 Hisamitsu TDS(Transdermal Delivery Systems) Sales, Revenue and Gross Margin (2016-2021)
12.10.4 Hisamitsu TDS(Transdermal Delivery Systems) Products Offered
12.10.5 Hisamitsu Recent Development
12.11 Mylan
12.11.1 Mylan Corporation Information
12.11.2 Mylan Business Overview
12.11.3 Mylan TDS(Transdermal Delivery Systems) Sales, Revenue and Gross Margin (2016-2021)
12.11.4 Mylan TDS(Transdermal Delivery Systems) Products Offered
12.11.5 Mylan Recent Development
12.12 Sorrento Therapeutics
12.12.1 Sorrento Therapeutics Corporation Information
12.12.2 Sorrento Therapeutics Business Overview
12.12.3 Sorrento Therapeutics TDS(Transdermal Delivery Systems) Sales, Revenue and Gross Margin (2016-2021)
12.12.4 Sorrento Therapeutics TDS(Transdermal Delivery Systems) Products Offered
12.12.5 Sorrento Therapeutics Recent Development
13 TDS(Transdermal Delivery Systems) Manufacturing Cost Analysis
13.1 TDS(Transdermal Delivery Systems) Key Raw Materials Analysis
13.1.1 Key Raw Materials
13.1.2 Key Raw Materials Price Trend
13.1.3 Key Suppliers of Raw Materials
13.2 Proportion of Manufacturing Cost Structure
13.3 Manufacturing Process Analysis of TDS(Transdermal Delivery Systems)
13.4 TDS(Transdermal Delivery Systems) Industrial Chain Analysis
14 Marketing Channel, Distributors and Customers
14.1 Marketing Channel
14.2 TDS(Transdermal Delivery Systems) Distributors List
14.3 TDS(Transdermal Delivery Systems) Customers
15 Market Dynamics
15.1 TDS(Transdermal Delivery Systems) Market Trends
15.2 TDS(Transdermal Delivery Systems) Drivers
15.3 TDS(Transdermal Delivery Systems) Market Challenges
15.4 TDS(Transdermal Delivery Systems) Market Restraints
16 Research Findings and Conclusion
17 Appendix
17.1 Research Methodology
17.1.1 Methodology/Research Approach
17.1.2 Data Source
17.2 Author List
17.3 Disclaimer